
Setmelanotide cut BMI 16.5% in a trial for acquired hypothalamic obesity, easing hyperphagia, though adverse events require close monitoring.

Christian Roth, MD, is a pediatrician and endocrinologist who serves as principal investigator at Seattle Children's Research Institute.

Setmelanotide cut BMI 16.5% in a trial for acquired hypothalamic obesity, easing hyperphagia, though adverse events require close monitoring.